Hiding In Plain Sight: Can TTS Pharma’s ‘Assured Advice’ Unlock UK’s CBD Mass Market?
Executive Summary
UK CBD supplier TTS Pharma believes its strategy of establishing partnerhips with local food law enforcement agencies as part of the "assured advice" scheme will unlock the country's cautious mass market. However, without proactive enforcement, the company worries that the UK food authority's legislative efforts to remove sub-standard CBD products from the market, as well as TTS' own efforts to become compliant, will be in vain.
You may also be interested in...
UK CBD Industry Embraces Trading Standards Partnership As Compliance Deadline Looms
UK CBD industry association, the ACI, joins others in forming partnerships with local authorities responsible for enforcing the new rules, which require all CBD food supplements on the market to hold a validated novel food application with the FSA. However, how effective enforcement will be in practice remains to be seen.
Ascension Launches CBD Oil Under UK Flexiseq Osteoarthritis Brand
UK-based Ascension Healthcare has launched Flexiseq CBD under its flagship joint-pain relief brand.
European Commission Decides CBD Is Not A Drug Opening Up Novel Food Pathway
The European Commission has unexpectedly concluded that CBD should not be considered as a drug opening up the path to a regulated EU market for the cannabinoid as a novel food.